Could a pinpoint radiation blast slow bone cancer spread?
NCT ID NCT03143322
First seen Jan 11, 2026 · Last updated May 24, 2026 · Updated 20 times
Summary
This study looks at whether adding a high-dose, precise type of radiation called SBRT to usual treatments (like hormone therapy or chemo) can delay cancer progression in people with 1 to 5 bone metastases from breast, lung, or prostate cancer. About 168 adults aged 18-75 with good general health are taking part. The goal is to see if this extra radiation improves how long the cancer stays under control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Amethyst CROM
Creil, France
-
Centre Catalan D'Oncologie
Perpignan, France
-
Centre Henri Becquerel
Rouen, France
-
Centre Léon Bérard
Lyon, France
-
Centre Léonard de Vinci
Dechy, France
-
Centre Marie Curie
Arras, France
-
Centre Oscar Lambret
Lille, France
-
Centre Pierre Curie
Beuvry, France
-
Centre d'oncologie et radiothérapie Saint-Jean
Saint-Doulchard, France
-
Centre de Cancérologie du Grand Montpellier
Montpellier, France
-
Chu Grenoble
Grenoble, France
-
Clinique Ambroise Pare
Beuvry, France
-
Clinique Tivoli Ducos
Bordeaux, France
-
Clinique des dentellières
Valenciennes, France
-
GCS RISSA - Institut de cancérologie Paris Nord
Sarcelles, France
-
Hôpital Henri Mondor
Créteil, France
-
Hôpital Métropole Savoie
Chambéry, France
-
Hôpital Privé Le Bois
Lille, France
-
Hôpital Privé Les Bonnettes
Arras, France
-
ICO - Site Paul Papin
Angers, France
-
Institut Bergonié
Bordeaux, France
-
Institut Jean Godinot
Reims, France
-
Institut Paoli Calmettes
Marseille, France
-
Institut Sainte Catherine
Avignon, France
-
Institut de Cancérologie de Bourgogne
Dijon, France
-
Institut de Cancérologie de Lorraine
Nancy, France
-
Institut de Cancérologie de l'Ouest
Nantes, France
-
Pôle Leonard de Vinci
Chambray-lès-Tours, France
Conditions
Explore the condition pages connected to this study.